![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1323, 2002-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Plerixafor: In Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma
Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Non-Hodgkin's Lymphoma in the Elderly
By Caimi Paolo F. Barr Paul M. Berger Nathan A. Lazarus Hillard M.
Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Rule Simon
Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemokines and antagonists in non-Hodgkin's lymphoma
By Golay Josée Introna Martino
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL in non-Hodgkin's and Hodgkins lymphoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :